Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fawaz O. Alenazy & Mark R. Thomas. (2021) Novel antiplatelet targets in the treatment of acute coronary syndromes. Platelets 32:1, pages 15-28.
Read now
Read now
Zhong-Guo Fan, Guo-Bin Ding, Xiao-Bo Li, Xiao-Fei Gao, Ya-Li Gao & Nai-Liang Tian. (2016) The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients. Drug Design, Development and Therapy 10, pages 3435-3448.
Read now
Read now
Shaun Bhatty, Asghar Ali, Ranjith Shetty, Kevin F Sumption, Michael J Cowley & Ion S Jovin. (2014) Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention. Expert Review of Cardiovascular Therapy 12:4, pages 463-474.
Read now
Read now
Articles from other publishers (14)
Paul Bamford, Nicholas Collins & Andrew Boyle. (2022) A State-of-the-Art Review: The Percutaneous Treatment of Highly Calcified Lesions. Heart, Lung and Circulation 31:12, pages 1573-1584.
Crossref
Crossref
Ben Rowland, Jonathan A. Batty, Roxana Mehran & Vijay Kunadian. 2022. Interventional Cardiology. Interventional Cardiology
453
464
.
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, Dimitri P. Mikhailidis & Antonis S. Manolis. (2021) Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications. The Journal of Clinical Pharmacology 62:3, pages 320-358.
Crossref
Crossref
Kallirroi Kalantzi, Nikolaos Tentolouris, Andreas J. Melidonis, Styliani Papadaki, Michail Peroulis, Konstantinos A. Amantos, George Andreopoulos, George I. Bellos, Dimitrios Boutel, Magdalini Bristianou, Dimitrios Chrisis, Nikolaos A. Dimitsikoglou, John Doupis, Chrysoula Georgopoulou, Stergios A. Gkintikas, Styliani Iraklianou, Κonstantinos Kanellas, Kalliopi Kotsa, Theocharis Koufakis, Maria Kouroglou, Anastasios G. Koutsovasilis, Leonidas Lanaras, Eirini Liouri, Charalampos Lixouriotis, Akrivi Lykoudi, Efthymia Mandalaki, Evanthia Papageorgiou, Nikolaos Papanas, Spyridon Rigas, Maria I. Stamatelatou, Ioannis Triantafyllidis, Aikaterini Trikkalinou, Aikaterini N. Tsouka, Ourania Zacharopoulou, Christos Zoupas, Ioannis Tsolakis & Alexandros D. Tselepis. (2021) Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events. Journal of the American Heart Association 10:1.
Crossref
Crossref
Shijie Zhao, Zhaoshuang Zhong, Guoxian Qi, Liye Shi & Wen Tian. (2018) Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials. Clinical Drug Investigation 39:1, pages 1-13.
Crossref
Crossref
Feng Huang. (2018) Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials. BMC Pharmacology and Toxicology 19:1.
Crossref
Crossref
Mei-Tzu Wang, Cheng Ken Tsai, Shu-Hung Kuo, Wei-Chun Huang, Kun-Chang Lin, Wang-Ting Hung, Chin-Chang Cheng, Pei-Ling Tang, Cheng Chung Hung, Jin-Shiou Yang, Hsin-Li Liang, Guang-Yuan Mar & Chun-Peng Liu. (2018) The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study. Frontiers in Neurology 9.
Crossref
Crossref
Ho-Jun Jang, Sang-Don Park, Hyun Woo Park, Jon Suh, Pyung Chun Oh, Jeonggeun Moon, Kyounghoon Lee, Woong Chol Kang, Sung Woo Kwon & Tae-Hoon Kim. (2017) Outcome of Triple Antiplatelet Therapy Including Cilostazol in Elderly Patients with ST-Elevation Myocardial Infarction who Underwent Primary Percutaneous Coronary Intervention: Results from the INTERSTELLAR Registry. Drugs & Aging 34:6, pages 467-477.
Crossref
Crossref
Jonathan A. Batty, Joseph R. Dunford, Roxana Mehran & Vijay Kunadian. 2017. Interventional Cardiology. Interventional Cardiology
443
452
.
Yu Luo, Jimin Li, Xu Liu, Jianfeng Xu, Zi Ye, Yian Yao, Xuebo Liu & Yan Lai. (2016) Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Thrombosis Research 139, pages 114-120.
Crossref
Crossref
Paik Seong Lim, Yachung Jeng, Ming Ying Wu, Mei-Ann Pai, Tsai-Kun Wu & Chang Hsu Chen. (2016) Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study. BioMed Research International 2016, pages 1-8.
Crossref
Crossref
Xin-Tian Zheng, Kang-Yin Chen, Tong Liu, Ling-Xia Xu, Jing-Jin Che, Seung-Woon Rha & Guang-Ping Li. (2016) Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention. Clinical and Experimental Pharmacology and Physiology 43:1, pages 29-33.
Crossref
Crossref
Niki Katsiki, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2015) Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly. Atherosclerosis 238:2, pages 182-184.
Crossref
Crossref
Jennifer K.W. Chesnutt & Hai-Chao Han. (2015) Simulation of the microscopic process during initiation of stent thrombosis. Computers in Biology and Medicine 56, pages 182-191.
Crossref
Crossref